|  Help  |  About  |  Contact Us

Publication : Atypical PKC, PKCλ/ι, activates β-secretase and increases Aβ<sub>1-40/42</sub> and phospho-tau in mouse brain and isolated neuronal cells, and may link hyperinsulinemia and other aPKC activators to development of pathological and memory abnormalities in Alzheimer's disease.

First Author  Sajan MP Year  2018
Journal  Neurobiol Aging Volume  61
Pages  225-237 PubMed ID  29032894
Mgi Jnum  J:258056 Mgi Id  MGI:6116560
Doi  10.1016/j.neurobiolaging.2017.09.001 Citation  Sajan MP, et al. (2018) Atypical PKC, PKClambda/iota, activates beta-secretase and increases Abeta1-40/42 and phospho-tau in mouse brain and isolated neuronal cells, and may link hyperinsulinemia and other aPKC activators to development of pathological and memory abnormalities in Alzheimer's disease. Neurobiol Aging 61:225-237
abstractText  Hyperinsulinemia activates brain Akt and PKC-lambda/iota and increases Abeta1-40/42 and phospho-tau in insulin-resistant animals. Here, we examined underlying mechanisms in mice, neuronal cells, and mouse hippocampal slices. Like Abeta1-40/42, beta-secretase activity was increased in insulin-resistant mice and monkeys. In insulin-resistant mice, inhibition of hepatic PKC-lambda/iota sufficient to correct hepatic abnormalities and hyperinsulinemia simultaneously reversed increases in Akt, atypical protein kinase C (aPKC), beta-secretase, and Abeta1-40/42, and restored acute Akt activation. However, 2 aPKC inhibitors additionally blocked insulin''s ability to activate brain PKC-lambda/iota and thereby increase beta-secretase and Abeta1-40/42. Furthermore, direct blockade of brain aPKC simultaneously corrected an impairment in novel object recognition in high-fat-fed insulin-resistant mice. In neuronal cells and/or mouse hippocampal slices, PKC-iota/lambda activation by insulin, metformin, or expression of constitutive PKC-iota provoked increases in beta-secretase, Abeta1-40/42, and phospho-thr-231-tau that were blocked by various PKC-lambda/iota inhibitors, but not by an Akt inhibitor. PKC-lambda/iota provokes increases in brain beta-secretase, Abeta1-40/42, and phospho-thr-231-tau. Excessive signaling via PKC-lambda/iota may link hyperinsulinemia and other PKC-lambda/iota activators to pathological and functional abnormalities in Alzheimer''s disease.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

6 Bio Entities

Trail: Publication

0 Expression